The inaugural Biomarkers & Diagnostics for Complex & Rare Diseases Summit will bring together discovery, translational, diagnostic and biomarker leaders for the advancement of precision medicine across neurology, cardiovascular, renal, rare disease, metabolic, dermatology and NASH indications. Uniting the pharmaceutical, biotech, Dx and healthcare industries, this meeting is the go-to platform for advancing the application of biomarkers and diagnostics to enhance precision medicine drug development, treatment decision making and patient outcomes in rare and complex diseases.

Driving case-study and data-led discussion, download your program for full presentation details and access to…

• Full BM&Dx speaker line up
• Detailed presentation topics from Eli Lilly & Co, Yumanity Therapeutics, Pfizer, Blue Cross Blue Shield Association and more
• Agenda layout and format of presentations, panels and networking activities

To receive your copy, download the brochure below.